Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients

Hua Wang,1–3,* Liang Wang,1–3,* Yue Lu,1–3 Xiaoqin Chen,1–3 Qirong Geng,1–3 Weida Wang,1–3 Zhongjun Xia1–3 1Department of Hematological Oncology, 2State Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Cen...

Full description

Bibliographic Details
Main Authors: Wang H, Wang L, Lu Y, Chen XQ, Geng QR, Wang WD, Xia ZJ
Format: Article
Language:English
Published: Dove Medical Press 2016-01-01
Series:OncoTargets and Therapy
Subjects:
Multiple myeloma
bortezomib;Prognostic factors;Peripheral neuropathy;Subcutaneous
Online Access:https://www.dovepress.com/long-term-outcomes-of-different-bortezomib-based-regimens-in-chinese-m-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/long-term-outcomes-of-different-bortezomib-based-regimens-in-chinese-m-peer-reviewed-article-OTT

Similar Items